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Abstract
Background The aim of this prospective, randomized,
single-blinded clinical trial was to compare the incidence of
chronicpainafterlaparoscopictransabdominalpreperitoneal
hernia repair (TAPP) using a 35-g/m
2 titanized polypropyl-
ene mesh and a 16-g/m
2 titanized polypropylene mesh. The
reportedincidenceofchronicpaininpatientswhounderwent
laparoscopic hernia repair is a serious problem. The tech-
niques of dissection, mesh ﬁxation, and the mesh material
used have all been identiﬁed as being part of the problem.
Excellent biocompatibility through a unique combination of
alightweightopenporouspolypropylenemeshcoveredwith
a covalent-bonded titanium layer has been claimed. The aim
of this study was to ﬁnd out whether the titanium surface
alone or the difference in material load between the two
available meshes inﬂuences clinical outcomes.
Methods Three hundred eighty patients with 466 inguinal
hernias were operated on between 2002 and 2006 with the
laparoscopic transabdominal preperitoneal (TAPP) tech-
nique. Mesh ﬁxation with staples was carried out routinely.
After the dissection was completed just prior to the
implantation of the mesh, patients were randomized into
two groups. In Group A, 250 (53.6%) inguinal hernias were
repaired with a 35-g/m
2 titanized polypropylene mesh, and
in Group B, 216 (46.4%) inguinal hernias were repaired
with a 16-g/m
2 titanized polypropylene mesh. The primary
outcome was chronic pain 3 years after surgery. The
degree of pain was determined using a visual analog scale
(VAS) with a range from 0 to 10. The secondary outcome
was the rate of recurrence.
Results The postoperative period of observation was at
least 3 years for every patient. In both groups, 90% of the
patients could be questioned and examined clinically: in
Group A (Light), 5.3% of the patients and in Group B
(Extralight), 1.5% of the patients suffered from chronic
pain. Chronic pain was signiﬁcantly more common in
Group A than in Group B (p = 0.037). There was no dif-
ference with respect to the rate of recurrence: for Group A
it was 3.1% and for Group B it was 2.6% (p = 0.724).
Conclusions Chronic pain is not very common in patients
who have had their inguinal hernias repaired with titanium-
covered polypropylene mesh. Reducing the material load
from 35 to 16 g/m
2 seems to further improve the bio-
compatibility of these meshes, thus improving the clinical
outcome by reducing chronic pain to a rare event. The role
of staples in causing chronic pain following inguinal hernia
repair may be overestimated. There was no evidence sup-
porting the notion that the use of the 16-g/m
2 titanized
meshes is associated with increased recurrence rates.
Keywords Hernia  Laparoscopy  TAPP  Pain 
Titanized polypropylene mesh
Introduction
Inguinal hernia repair is one of the most commonly per-
formed operations in the world. Every year almost 60,000
inguinal hernia repairs (IHR) using transabdominal pre-
peritoneal (TAPP) and extraperitoneal (TEP) techniques
are performed in Germany [1]. In the majority of cases
postoperative recovery is without complications and
return to normal activities is possible within 1 week [2].
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for several weeks and some suffer from chronic groin pain
for months or even for years. Chronic pain was deﬁned as
‘‘lasting for 3 months or more’’ using the deﬁnition of the
International Association for the Study of Pain [3]. In their
meta-analysis of randomized controlled trials, McCormack
et al. found the incidence of chronic pain after inguinal
herniarepairusingtheTAPPtechniquetobeat13.8%[4].In
the literature, several risk factors for chronic inguinal pain
are mentioned. These are young age, female gender, medial
hernia, open repair technique, postoperative complications,
need for operation for recurrence [5], presence of preoper-
ative pain, neurotoxic chemotherapy, depression, neuroti-
cism, anxiety [6, 7], and an observation period of fewer than
3 yearsaftersurgery[8].However,thestaplesusedformesh
ﬁxation [9] and the alloplastic mesh itself may also be major
causes for chronic postoperative pain [10].
Animal studies proved that there is a correlation between
the weight, biocompatibility, and shrinkage of polypropyl-
ene meshes [10]. There have been numerous clinical reports
pointing out the tendency of implanted mesh to shrink
extensively and migrate and penetrate neighboring organs,
have an oversized load of material, and cause an associated
chronic inﬂammatory reaction and even carcinogenic
effects [10–12]. A great effort was put into the development
of meshes that have improved biocompatibility.
Since 2001 titanium-covered polypropylene meshes,
referring to a new type of compound material, are avail-
able. The titanium is covalently bonded to the alloplastic
surface of the mesh. There is evidence from animal
experiments that the titanium-coated polypropylene
meshes induce a less pronounced foreign body reaction
(i.e., less shrinkage) compared with identical meshes
lacking a titanium coating [13].
To improve the outcome for their patients some sur-
geons have begun performing inguinal hernia repair using
these titanized meshes. However, it was not clear which
mesh to use for which kind of hernia, and it was also not
clear how the 35-g/m
2 (Light) and the 16-g/m
2 (Extralight)
versions differed concerning the rate of recurrence or
chronic pain [14].
The aim of this prospective, randomized, single-blinded
clinical trial was to compare the incidence of chronic
inguinal pain and the rate of recurrence after laparoscopic
transabdominal preperitoneal (TAPP) hernia repair using
35-g/m
2 (Light) and 16-g/m
2 (Extralight) titanized poly-
propylene mesh.
Methods
Patients who were at least 18 years old and presented at the
General Surgery Unit of Agatharied Academic Teaching
Hospital of the Ludwig-Maximilians-University of Munich
with a diagnosis of an inguinal or a femoral hernia were
eligible to enter the study. The hernia repair was to be a
laparoscopic tension-free TAPP technique with mesh ﬁx-
ation using titanium staples. Patients were randomized
intraoperatively to receive either a 35-g/m
2 (TiMESH-
Light
TM, pfm medical ag, Cologne, Germany) or a 16-g/m
2
(TiMESH-Extralight
TM, pfm medical ag) mesh for the
repair of the inguinal hernia. The protocol was approved by
the Institutional Review Board of the Ludwig-Max-
imilians-University of Munich (Ethical Committee) and
informed consent was obtained from all participants.
All patients who were class IV or class V as deﬁned by
the American Society of Anesthesiologists (ASA) were
excluded, as were those who had contraindications for
general anesthesia. Further exclusion criteria were acute
intra-abdominal infection such as peritonitis, previous
major abdominal procedures, or a history of ileus. Patients
who were participating in another trial, younger than
18 years, and mentally immature were also excluded.
Randomization was carried out using a lottery system.
Letters were prepared prior to starting the trial and stored in
a box. Each letter was drawn from the box and opened by a
nurse just after dissection of the inguinal region and
hemorrhage control were ﬁnished. The only inﬂuence that
the surgeon had was the choice of the size of the mesh to be
10 9 15 cm or larger. In patients with bilateral hernias,
both sides were repaired with the same type of mesh.
Patients were not aware of which kind of mesh was used
for the repair. During the consent process (Fig. 1) prior to
entering the trial, patients were informed that two new
types of titanized polypropylene meshes are available and
that we wanted to ﬁnd out which one is the better with
respect to postoperative pain and recurrence.
All patients underwent standardized TAPP repair in the
presence of a surgeon experienced in TAPP repair who
either performed the procedure himself or supervised it in a
teaching situation. There were 13 surgeons who performed
the operations. General anesthesia was used in all cases.
All patients received standardized postoperative oral pain
medication consisting of diclofenac 2 9 50 mg, novam-
insulfone 4 9 500 mg, and omeprazole 1 9 20 mg. Four
times per day pain levels were routinely controlled using
the VAS ranging from 1 to 10. If at any time levels above
VAS 3 were detected, additional medication (oxycodone/
naloxone [Targin
] 10 mg or piritramide [Dipidolor
]
15 mg) was administered until the patient reported levels
below VAS 3. All patients were given standardized post-
operative instructions that did not limit their activities.
They could participate in sports as usual within the ﬁrst
10 days except heavy-weight body building and anything
that caused high-frequency movements of the psoas mus-
cle, e.g., mountain biking.
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The herniotomy was carried out with the patient under
general anesthesia with a single shot of prophylactic anti-
biotic (cefuroxime 750 mg). The operation was performed
with the patient in the Trendelenburg position. The bladder
was drained using a catheter. After pneumoperitoneum was
induced, the 10-mm optic trocar was introduced at the
umbilicus. Following inspection of the abdomen and the
hernia, a 5-mm trocar was placed at the left lateral mid-
clavicle. On the right lateral midclavicular line, a 12-mm
trocar was placed to insert the stapler.
From the umbilical artery medially to 4–6 cm past the
inguinal ring laterally, the abdominal wall (peritoneum)
was incised describing an arc. The epigastric vessels were
identiﬁed. The medial compartment was completely dis-
sected to the midline, exposing the rectus muscle, the
horizontal pubic ramus, Hesselbach’s triangle, Cooper’s
ligament, and the iliopubic tract. The femoral hernia oriﬁce
was exposed. The dissection went deep into the prevesical
space. The peritoneum was dissected from the spermatic
cord cranially to about midpsoas. In lateral hernias, the sac
was completely reduced and separated from the deferent
duct and testicular vessels. In direct hernias, the pseudosac
was completely dissected and the hernia oriﬁce was freed
from tissue. Perihernial lipomas were excised. In all cases,
titanized meshes, either TiMESH-Light or TiMESH-
Extralight (15 cm 9 10 cm or 15 cm 9 15 cm mostly cut
down to 15 9 12 cm) were used. Meshes were not incised.
Staple ﬁxation of the mesh was done in the vast majority
of repairs. In special cases, e.g., extremely large hernias,
suture ﬁxation was used, and in very small lateral hernias
no ﬁxation was used. Mesh was ﬁxed with two to six
titanium staples by using either an Endopath Multiﬁre
stapler (EMS, Ethicon Endo-Surgery Inc., Cincinnati, OH,
USA) or an Endo-Universal stapler (Auto-Suture, Covidi-
en, Mansﬁeld, MA, USA). One staple each was placed at
the transverse fascia at the ventral border of the mesh
medially and laterally to the epigastric vessels. The other
staples were optional and were placed as follows: one
staple to Cooper’s ligament, one to the suprapubic con-
nective tissue in the midline, and the last staple could be
variably placed, always keeping at least a 3-cm safety
distance to the inguinal ligament.
Fig. 1 Design of the study
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running suture. In patients with bilateral hernias, the same
procedure was performed on both sides. The placement of
one Redon drain (Suru International, Mumbai, India) at the
end of the procedure was optional. After removal of the
trocars, the umbilical port site was closed at the level of the
fascia. The skin was sutured. Umbilical hernias, when
detected, were closed simultaneously by suture.
Primary outcome
The primary outcome of the trial was chronic inguinal pain
more than 3 years after inguinal hernia repair with TAPP
technique. Chronic pain was deﬁned as pain that persisted
for more than 3 months after surgery and was present at the
time of follow-up examination. It included patients who
regularly consumed painkillers to control inguinal pain
after hernia repair at the time of follow-up examination.
The postoperative follow-up period for every hernia was at
least 3 years. All patients were personally questioned and
examined in detail at least 3 years after surgery by the
same examiner.
Measurement of pain for all patients was also performed
by only one examiner who used a standardized pain pro-
tocol (Table 1). The intensity was measured with a 10-cm
VAS from 0 (no pain) to 10 (agonizing). Patients
describing persistent pain were referred for further neuro-
logical, orthopedic, urological, gynecological, and psychi-
atric investigation (Fig. 2). When no extrainguinal cause
for the pain could be found, the pain was considered to be a
result of the procedure.
Patients who described postoperative pain at the time of
the follow-up examination which, according to memory,
subsided within 3 months after surgery did not limit their
activities and returned to their prehernia lifestyles. They
were documented to have suffered from acute pain. This
historic perspective of the patient’s postoperative period
was soft data that was not considered to be a primary
outcome measure.
Secondary outcomes
Secondary outcomes were early and late recurrences rates.
Recurrences were conﬁrmed by clinical examination,
ultrasound, and, in some cases, laparoscopy.
Statistics
The study was designed to detect a 3% difference in
chronic inguinal pain between the groups, with a sample of
at least 200 hernias per group, a power of 70%, and an a
error of 5%. The results were analyzed using multiple
logistic regression (SPSS 15.0 for Windows and Microsoft
Excel 2000). In the primary analysis, the rates of chronic
inguinal pain in patients who received TiMESH-Extralight
and TiMESH-Light were compared. The values are
expressed as median ﬁrst and third quartile, mean and
Table 1 Hernia follow-up: standardized pain protocol accounted for
every single hernia repaired
1. Do you have any pain in relation to
the hernia repair?
Pain, no pain
2. How often do you have pain related
to the hernia repair?
Every day, once in the
week, occasionally
3. How strong is the pain on a visual
analog scale 0 to 10?
0 no pain, 10 the strongest
pain
4. How much does this pain affect your
daily life?
No problem, a little, very
limiting
5. Do you need painkillers? Every day, once in the
week, occasionally
6. What sort of painkillers do you use?
7. For how long have you been using
these painkillers?
Few days, weeks, months
TiMESH-Extralight
(N = 194 single
hernias)
TiMESH-Light
(N = 225 single
hernias)
Do you have any pain related to the hernia repair?
Yes 3 12
No 191 213
How often do you have pain related to the hernia repair?
Every day 3 6
Once a week 0 5
Occasionally 0 1
How strong is the pain on a visual analog scale of 0 to 10?
VAS 0 191 213
VAS 1 0 1
VAS 2 0 2
VAS 3 0 3
VAS 4 0 2
VAS 5 0 2
VAS 6 0 1
VAS 7 1 0
VAS 8 2 1
VAS 9 0 0
VAS 10 0 0
How much does this pain affect your daily life?
No problem 191 213
Little 0 6
Very limiting 3 6
Do you need painkillers?
Yes 3 12
No 191 213
What sort of painkillers do you use?
NSAR 3 12
Acupuncture 2 0
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123range, or relative frequencies. A one-sided P\0.05 was
considered signiﬁcant.
Results
Baseline characteristics of the patients
Between October 2002 and January 2006, all 380 patients
with 466 inguinal hernias underwent inguinal hernia repair
with the TAPP technique. The 3-year follow-up period for
the last patient ended in January 2009. Of the 380 patients
operated on, 344 came personally for a physical exami-
nation and questioning in detail, for a follow-up rate of
90%. The response rate was the same in both groups:
90.0% (225 of 250 hernias) for Group A (Light) and 89.8%
(194 of 216 hernias) for Group B (Extralight).
Table 2 shows the baseline characteristics of the patients
according to the two treatment groups. Demographic
characteristics, the characteristics of hernia, and ASA
classiﬁcation were similar in both groups. There was no
statistical difference (P[0.05, Table 2).
Chronic pain
Postoperative pain was reported by 75 of 419 (17.9%)
investigated inguinal hernias. In 60 patients, the pain fell
into the category of acute and was limited to the immediate
postoperative period of 3 months or less. Acute pain was
more common in Group B (Extralight), with 22.4%, than in
Physical examination for exclusion of a
recurrent, femoral or obturator hernia 
Exact history of the pain and psycho-social history 
Referral to Urologist Referral to 
Gynecologist  
Referal to Orthopedic Surgeon,
Neurologist, Psychiatrist 
Absence of other causes for pain and persistence for more than 3 
months  chronic inguinal pain 
Male patient Female patient
Fig. 2 Approach to patients with pain
Table 2 Baseline
characteristics of the patients
according to treatment group
TiMESH-Light TiMESH-Extralight P value
No. all patients (n = 380) n = 206 n = 174
Number of all hernias (n = 466) n = 250 n = 216
N % N %
Age (years) 55.6 51.3
Gender 0.86
Male 174 84.50 148 85
Female 32 15.50 26 15
Side 0.88
Right 136 54.40 119 55.10
Left 114 45.60 97 44.90
ASA 0.07
ASA 1 106 51.50 109 62.60
ASA 2 73 35.40 51 29.30
ASA 3 27 13.10 14 8.10
0.42
Primary hernia 210 84 188 87
First recurrent hernia 36 14.40 23 10.60
Hernia recurrent more than once 4 1.60 5 2.40
0.13
Emergency intervention 11 5.30 4 2.30
Elective surgery 195 94.60 170 97.70
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123Group A (Light), with only 13.2%. The difference, how-
ever, was not signiﬁcant (P[0.05).
In 15 inguinal hernia cases (3.6%), patients reported
chronic inguinal pain. Of these 15 inguinal hernias, 3
(1.5%) in two patients were found in Group B (Extralight)
and 12 (5.3%) in Group A (Light). Chronic inguinal pain
was signiﬁcantly more common after implantation of
TiMESH-Light mesh than after implantation of TiMESH-
Extralight mesh (P = 0.037, Fig. 3). There were no intra-
operative complications in any of these 15 patients with
chronic pain during the postoperative course. There were
no documented lesions to the spermatic cord, the nerves, or
the blood vessels. One of the 15 patients with chronic
inguinal pain suffered from a recurrent hernia. One patient
in the TiMESH-Light group who had bilateral hernia repair
had both meshes removed because the pain had been so
severe. In the TiMESH-Light group, one case with chronic
pain occurred after the repair of a recurrent hernia. We
found no effect of the operating surgeon on the occurrence
of chronic inguinal pain in the data collected.
In Group A, one inguinal hernia repair was an emer-
gency intervention. All other 14 hernia repairs were
performed as elective surgery. Figure 4 shows the intensity
of chronic pain in the Group A (Light) and in Group B
(Extralight).
Recurrences
In the 3-year observation period, 12 recurrent hernias
(2.86%) were found by postoperative investigation. Hernia
recurrence was more common in Group A (Light), with
seven hernias (3.1%), than in Group B (Extralight), with
ﬁve hernias (2.6%). The difference, however, was not
signiﬁcant (P = 0.724, Fig. 5). All recurrent hernias were
repaired in a second operation. There were no more com-
plications in any of the patients.
Discussion
In the past, the recurrence rate was a major outcome
measure in studies dealing with inguinal hernia repair
(IHR). Meanwhile, the attention has turned to other mea-
sures of success. Chronic pain has become a major focus in
the last few years and there have been numerous studies
dealing with pain after IHR, its type and frequency of
occurrence, its risk factors, and proﬁles of patients pre-
disposed to the condition. The roots of the problem are
nerve injury, tissue injury, the material used for the repair,
and the method of mesh ﬁxation. Anatomical changes also
might be a cause [15].
We found in our prospective, randomized, single-blin-
ded trial that 3 years after IHR with the TAPP technique
5.3% of the patients suffered from chronic pain after the
implantation of the 35-g/m
2 titanized polypropylene mesh
(TiMESH-Light). After hernia repair with the 16-g/m
2 tit-
anized polypropylene mesh (TiMESH-Extralight), which
made up the second arm in the trial, chronic pain was
Fig. 3 Distribution of chronic pain
Fig. 4 Intensity of chronic pain on a visual analog scale
Fig. 5 Recurrence rate in both groups
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123detected in only 1.5% of the patients. This difference was
signiﬁcant (P = 0.037). The only difference between the
two meshes was the material load. There was no difference
in the baseline characteristics between the groups, so the
reduction in chronic pain in Group B can be attributed only
to the lighter-weight mesh. This is in line with the exper-
imental results of Junge et al. [16] who very clearly dem-
onstrated signiﬁcantly improved functional consequences
and morphologic tissue response with material-reduced
mesh compared to a common heavy-weight polypropylene
mesh. Klosterhalfen et al. [11] found in histological studies
of long-term implanted meshes that the reduction of mesh
material reduced the acute inﬂammatory reaction, caused
less formation of connective tissue, and hardly maintained
a chronic inﬂammatory process. There is much experi-
mental evidence in the literature that material composition
and mesh structure may signiﬁcantly affect foreign body
reaction [17]. A recent extensive review by Weyhe et al. of
current randomized controlled trials and retrospective
studies led to the conclusion that light meshes seem to have
some advantages with respect to postoperative pain and
foreign body sensation [17]. However, Light meshes offer
no advantage with respect to alleviating ‘‘severe chronic
groin pain.’’ We conﬁrmed this in our study. The only two
patients in the TiMESH-Extralight group with chronic pain
reported it to be quite strong. Weyhe et al. also found that
the use of Light meshes was associated with an increased
recurrence rate [17]. In the present study we did not ﬁnd a
difference between the 35- and the 16-g/m
2 versions with
respect to recurrence. Nonetheless, light-weight meshes
have replaced their heavy-weight counterparts almost
completely. This is clinical reality today, and it is inde-
pendent of the fact that it may be difﬁcult to prove why
these Light meshes are favored. In our study, the lower rate
of chronic pain detected in the arm with the lighter mesh
conﬁrmed expectations.
In a recent review of the literature, the incidence of
chronic pain after IHR was reported to range between 25
and 30% in the majority of studies, with 2-9% reported as
severe pain [18]. McCormack et al. found that the inci-
dence of chronic pain after IHR with TAPP technique was
13.8% in a meta-analysis of randomized controlled trials
[4], which was more than 5% lower than for the examined
open repairs. Aasvang and Kehlet found in their review of
the present literature that inguinal herniorrhaphy may be
followed by a risk of chronic pain in about 12% of patients
(18% after open and 6% after laparoscopic repair), with a
clinically signiﬁcant effect on daily activities [19]. Grant
et al. [20] found pain and numbness to be less of a problem
after laparoscopic repair than after open repair. A well-
conducted, large, randomized controlled multicenter trial
found a 10% incidence of chronic pain after laparoscopy
and 14% after open surgery in 1983 patients (P\0.05)
without signiﬁcant differences in VAS scores between the
two groups at 6, 12, and 24 months. Kroninger [21]
reported chronic pain at a rate of 15% after TAPP repair in
a long-term follow up ([52 months).
Several trials reported the incidence of chronic pain due
to IHR after a follow-up of 1 year [4]. Our patients were
followed up for 3 years after surgery, so the number of
patients feeling pain may be reduced as a result of the
follow-up time interval used. Courtney et al. [22] used the
Wisconsin Brief Pain Questionnaire, which measures pain
severity and the impact of pain on function using 0-10
rating scale, to assess the long-term outcomes in 126
patients who reported severe or very severe pain within
3 months after IHR. Of the 86 who responded after
2.5 years, 71% still reported pain, which was severe or
very severe in 26% of the cases and mild or very mild in
45% of the cases. This study demonstrates that the number
of patients complaining and the severity of the pain both
diminish over time. However, despite some available data,
there is an overall lack of well-designed prospective studies
quantifying the time course of post-herniorrhaphy pain.
Even in view of the evidence suggesting a ‘‘burn-out’’
effect of the pain complaints, we ﬁnd that the very low rate
detected in both of our TiMESH groups cannot be attrib-
uted only to the time factor.
The incidence of short- or long-term chronic pain after
laparoscopic IHR with TAPP technique as reported in the
literature is generally higher than the results of the present
trial. Chronic pain in 5.3% of the patients after 3 years after
IHR with TAPP technique using 35-g/m
2 titanized poly-
propylene mesh (Light) offers a good result in comparison
with the literature. A rate of 1.5% when 16-g/m
2 titanized
polypropylene mesh (Extralight) is used can be classiﬁed
as a rare event. The data are rather solid since it is derived
from a prospective randomized study with a large sample
size of 466 hernias repairs and a high-quality follow-up,
i.e., physical examination and personal questioning of 90%
of the patients operated on. de Jonge et al. [23] stated after
an extensive review of randomized trials, considered to be
the ‘‘gold standard’’ of evidence, that the majority were
using the VAS to assess pain, suggesting that there is a
certain amount of standardization that can better enable
interstudy comparison. Even though this particular quality
standard was met by the present study, current instruments
used for the evaluation of chronic pain need to be improved
and prospectively validated.
The mesh used is the most probable reason for the low
rate of chronic pain in this study. There are several modern
concepts integrated into these prosthetic meshes, such as
the light weight, pore size C 1m m[ 12], monoﬁle ﬁber,
and titanium surface, that may have made a clinical dif-
ference, at least in this study, when compared to other
meshes used in hernia repair. The low rate of chronic pain
308 World J Surg (2011) 35:302–310
123detected in both groups in the present study may have to do
not only with the reduced weight but also with the unique
titanium surface. With respect to several histological and
histochemical parameters of biocompatibility, the titanized
polypropylene mesh proved advantageous compared with
the other modern meshes in animal experiments. Heavy-
weight titanium-coated polypropylene meshes induce a less
pronouncedforeignbodyreactionthanidenticalmesheswith
no titanium coating. Since the amount of material implanted
is identical, this must be attributed solely to the titanium
coating [13]. The favorable biocompatibility of the titanized
meshes that supposedly cause less foreign body reaction and
less shrinkage than other modern meshes as demonstrated in
animal experiments [13, 24] may also hold true in humans.
What causes the pain in those patients still suffering after
3 years? In addition to the mesh there is surgical trauma,
direct nerve injury, and the use of staples that may have also
played a role here. There are numerous published reports of
nerveentrapmentbytacksplacedduringlaparoscopicrepair.
Laparoscopic hernia repair [25] without the use of tacks has
been described and it eliminates the risk of misplaced tacks
[26].Inaddition,itismorecosteffectivebecausestaplersare
expensive.Othersdoadvisetousestaplesbecausetherateof
recurrencemaybereduced [27].Inthepresentstudy, staples
were used in both groups to an equal extent. The rate of
recurrence was the same in both groups but not the rate of
chronic pain. The role of staples as a major cause of chronic
inguinal pain cannot be supported by our data.
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